» Authors » Josef Kautzner

Josef Kautzner

Explore the profile of Josef Kautzner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 350
Citations 8936
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cvek J, Jiravsky O, Knybel L, Hudec M, Spacek R, Reichenbach A, et al.
Radiat Oncol . 2025 Mar; 20(1):33. PMID: 40065371
Background: This intervention pilot case series assessed 40-Gy stereotactic radiosurgery (SRS) neuromodulation applied to the bilateral stellate ganglion (SG) as a bailout procedure for patients with refractory angina pectoris (RAP)....
2.
Kiehl E, Mountantonakis S, Mansour M, Nair D, Sharma D, Taigen T, et al.
Heart Rhythm . 2025 Feb; PMID: 39922404
Background: The SPHERE Per-AF trial demonstrated noninferiority for a primary composite effectiveness endpoint in patients with persistent atrial fibrillation (AF) treated with a 9-mm, lattice-tip, pulsed field (PF)/radiofrequency (RF) system...
3.
Kautzner J, Moreno J, Tondo C, Anselme F, Burrell J, Becker D, et al.
J Interv Card Electrophysiol . 2025 Feb; PMID: 39893296
Background: Catheter ablation using radiofrequency (RF) energy is an established treatment for ventricular tachycardia (VT). Tissue temperature is a key determinant of successful lesion creation, and yet, it is difficult...
4.
Scherr D, Turagam M, Maury P, Blaauw Y, van der Voort P, Neuzil P, et al.
Europace . 2025 Jan; PMID: 39824172
Background: Initial clinical studies of pulsed field ablation (PFA) to treat atrial fibrillation (AF) indicated a >90% durability rate of pulmonary vein isolation (PVI). However, these studies were largely conducted...
5.
Sedova K, Azarov J, Van Dam P, Necasova L, Kukla J, Sramko M, et al.
J Cardiovasc Electrophysiol . 2024 Dec; 36(2):338-346. PMID: 39618333
Introduction: A variable proportion of non-responders to cardiac resynchronization therapy (CRT) warrants the search for new approaches to optimize the position of the left ventricular (LV) lead and the CRT...
6.
Marek J, Stojadinovic P, Wichterle D, Peichl P, Haskova J, Borisincova E, et al.
J Cardiovasc Electrophysiol . 2024 Nov; 36(1):256-265. PMID: 39588593
Introduction: Atrial fibrillation (AF) can cause or aggravate heart failure (HF). Catheter ablation (CA) is an effective treatment for AF. This study focused on the feasibility and outcomes of emergent...
7.
Peichl P, Wichterle D, Schlosser F, Stojadinovic P, Nejedlo V, Borisincova E, et al.
Europace . 2024 Oct; 26(11). PMID: 39478679
Aims: Catheter ablation is an effective treatment method for recurrent ventricular tachycardias (VTs). However, at least in part, procedural and clinical outcomes are limited by challenges in generating an adequate...
8.
Stojadinovic P, Ventrella N, Alfredova H, Wichterle D, Peichl P, cihak R, et al.
J Cardiovasc Electrophysiol . 2024 Oct; 35(12):2405-2410. PMID: 39400487
Introduction: Pulsed electric field (PEF) has emerged as a promising energy source for catheter ablation of atrial fibrillation (AF). However, data regarding the in-vivo effect of PEF energy on erythrocytes...
9.
Peek N, Hindricks G, Akbarov A, Tijssen J, Jenkins D, Kapacee Z, et al.
Eur Heart J . 2024 Oct; 45(43):4616-4626. PMID: 39378245
Background And Aims: Risk stratification of sudden cardiac death after myocardial infarction and prevention by defibrillator rely on left ventricular ejection fraction (LVEF). Improved risk stratification across the whole LVEF...
10.
Kalinoski H, Daoud A, Rusinkevich V, Jurcova I, Talor M, Welsh R, et al.
Proc Natl Acad Sci U S A . 2024 Oct; 121(42):e2323052121. PMID: 39378095
Cardiac myosin-specific (MyHC) T cells drive the disease pathogenesis of immune checkpoint inhibitor-associated myocarditis (ICI-myocarditis). To determine whether MyHC T cells are tissue-resident memory T (T) cells, we characterized cardiac...